Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.56 USD | +2.53% | +9.38% | -13.04% |
06-14 | Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $45 From $48, Keeps Neutral Rating | MT |
06-14 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Friday | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.04% | 3.67B | |
+16.59% | 122B | |
+20.43% | 115B | |
+21.22% | 26.64B | |
-23.24% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-19.03% | 15.49B | |
+61.53% | 14.83B | |
+3.16% | 13.67B |
- Stock Market
- Equities
- RARE Stock
- News Ultragenyx Pharmaceutical Inc.
- Transcript : Ultragenyx Pharmaceutical Inc. Presents at Bank of America Securities 2023 Healthcare Conference, May-10-2023 09